Tucidinostat Plus R-CHOP for Large B-Cell Lymphoma

To the Editor Dr Xu and colleagues conducted an important randomized study evaluating the efficacy and safety of tucidinostat added to standard rituximab plus cyclophosphamide, doxorubicin, vincris...